The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125692172 12569217 2 F 20160602 20160715 20160719 20160727 EXP PHEH2016US016911 NOVARTIS 69.00 YR F Y 83.20000 KG 20160727 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125692172 12569217 1 PS RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 Oral 10187
125692172 12569217 2 SS ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral UNK 0
125692172 12569217 3 SS SUTENT SUNITINIB MALATE 1 Oral 50 MG, QD (CYCLIC) 1450 MG 0 50 MG CAPSULE QD
125692172 12569217 4 SS SUTENT SUNITINIB MALATE 1 Oral UNK 1450 MG 0 CAPSULE
125692172 12569217 5 SS LIPITOR ATORVASTATIN CALCIUM 1 Oral UNK 0 FILM-COATED TABLET
125692172 12569217 6 SS AMLODIPINE BESILATE AMLODIPINE BESYLATE 1 Oral 0 FILM-COATED TABLET
125692172 12569217 7 SS ZOLOFT SERTRALINE HYDROCHLORIDE 1 Oral UNK 0
125692172 12569217 8 SS LEVOTHYROXINE SODIUM. LEVOTHYROXINE SODIUM 1 Oral UNK 0 TABLET
125692172 12569217 9 SS PHENERGAN PROMETHAZINE HYDROCHLORIDE 1 Oral UNK 0
125692172 12569217 10 SS XARELTO RIVAROXABAN 1 Oral UNK 0
125692172 12569217 11 SS BUPROPION. BUPROPION 1 Oral UNK 0
125692172 12569217 12 SS TRAZODONE TRAZODONE HYDROCHLORIDE 1 Oral UNK 0
125692172 12569217 13 C ATROPINE. ATROPINE 1 Unknown 0.5 MG, QD U 0 .5 MG QD
125692172 12569217 14 C DOPAMINE DOPAMINEDOPAMINE HYDROCHLORIDE 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125692172 12569217 1 Fatigue
125692172 12569217 2 Nausea
125692172 12569217 3 Salivary gland cancer
125692172 12569217 5 Hyperlipidaemia
125692172 12569217 6 Hypertension
125692172 12569217 7 Depression
125692172 12569217 8 Hypothyroidism
125692172 12569217 9 Nausea
125692172 12569217 10 Embolism
125692172 12569217 11 Depression
125692172 12569217 12 Depression
125692172 12569217 13 Product used for unknown indication
125692172 12569217 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125692172 12569217 DS
125692172 12569217 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125692172 12569217 Sinus bradycardia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125692172 12569217 1 20160411 0
125692172 12569217 2 20160516 0
125692172 12569217 3 20160411 20160509 0
125692172 12569217 4 20160523 20160602 0
125692172 12569217 5 20130101 0
125692172 12569217 6 20120101 0
125692172 12569217 7 20150101 0
125692172 12569217 8 19900101 0
125692172 12569217 9 20160516 0
125692172 12569217 10 20160517 0
125692172 12569217 11 20151001 0
125692172 12569217 12 20150101 0